Monday, December 27, 2010

Odanon




Odanon may be available in the countries listed below.


Ingredient matches for Odanon



Carbazochrome

Carbazochrome sodium sulfonate (a derivative of Carbazochrome) is reported as an ingredient of Odanon in the following countries:


  • Japan

International Drug Name Search

Sunday, December 26, 2010

Bromazepam EG




Bromazepam EG may be available in the countries listed below.


Ingredient matches for Bromazepam EG



Bromazepam

Bromazepam is reported as an ingredient of Bromazepam EG in the following countries:


  • Belgium

  • Italy

International Drug Name Search

Wednesday, December 22, 2010

Urocarb




Urocarb may be available in the countries listed below.


Ingredient matches for Urocarb



Bethanechol

Bethanechol Chloride is reported as an ingredient of Urocarb in the following countries:


  • Australia

International Drug Name Search

Sunday, December 19, 2010

Arelix




Arelix may be available in the countries listed below.


Ingredient matches for Arelix



Piretanide

Piretanide is reported as an ingredient of Arelix in the following countries:


  • Brazil

  • Germany

  • Ireland

  • Japan

  • Luxembourg

  • South Africa

  • Switzerland

International Drug Name Search

Tuesday, December 14, 2010

Azathioprin Copyfarm




Azathioprin Copyfarm may be available in the countries listed below.


Ingredient matches for Azathioprin Copyfarm



Azathioprine

Azathioprine is reported as an ingredient of Azathioprin Copyfarm in the following countries:


  • Denmark

  • Sweden

International Drug Name Search

Monday, December 13, 2010

Kemanat




Kemanat may be available in the countries listed below.


Ingredient matches for Kemanat



Ketorolac

Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Kemanat in the following countries:


  • Argentina

International Drug Name Search

Thursday, December 9, 2010

Droll




Droll may be available in the countries listed below.


Ingredient matches for Droll



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Droll in the following countries:


  • Greece

International Drug Name Search

Wednesday, December 8, 2010

Tensimin




Tensimin may be available in the countries listed below.


Ingredient matches for Tensimin



Atenolol

Atenolol is reported as an ingredient of Tensimin in the following countries:


  • India

  • Philippines

International Drug Name Search

Tuesday, December 7, 2010

Sülpir




Sülpir may be available in the countries listed below.


Ingredient matches for Sülpir



Sulpiride

Sulpiride is reported as an ingredient of Sülpir in the following countries:


  • Turkey

International Drug Name Search

Bromazépam Ratiopharm




Bromazépam Ratiopharm may be available in the countries listed below.


Ingredient matches for Bromazépam Ratiopharm



Bromazepam

Bromazepam is reported as an ingredient of Bromazépam Ratiopharm in the following countries:


  • France

International Drug Name Search

Monday, December 6, 2010

Paroxetin Sandoz




Paroxetin Sandoz may be available in the countries listed below.


Ingredient matches for Paroxetin Sandoz



Paroxetine

Paroxetine hydrochloride (a derivative of Paroxetine) is reported as an ingredient of Paroxetin Sandoz in the following countries:


  • Denmark

  • Estonia

  • Germany

  • Lithuania

  • Netherlands

  • Sweden

International Drug Name Search

Thursday, December 2, 2010

Baméthan




Baméthan may be available in the countries listed below.


Ingredient matches for Baméthan



Bamethan

Baméthan (DCF) is also known as Bamethan (Rec.INN)

International Drug Name Search

Glossary

DCFDénomination Commune Française
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, November 23, 2010

Colistin Sodium Methanesulfonate




Colistin Sodium Methanesulfonate may be available in the countries listed below.


Ingredient matches for Colistin Sodium Methanesulfonate



Colistin Sulfate

Colistin Sodium Methanesulfonate (JAN) is known as Colistin Sulfate in the US.

International Drug Name Search

Glossary

JANJapanese Accepted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Biso-Puren comp




Biso-Puren comp may be available in the countries listed below.


Ingredient matches for Biso-Puren comp



Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Biso-Puren comp in the following countries:


  • Germany

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Biso-Puren comp in the following countries:


  • Germany

International Drug Name Search

Bisacodyl Samenwerkende Apothekers




Bisacodyl Samenwerkende Apothekers may be available in the countries listed below.


Ingredient matches for Bisacodyl Samenwerkende Apothekers



Bisacodyl

Bisacodyl is reported as an ingredient of Bisacodyl Samenwerkende Apothekers in the following countries:


  • Netherlands

International Drug Name Search

Tuesday, November 16, 2010

Bisacodyl Nizhpharm




Bisacodyl Nizhpharm may be available in the countries listed below.


Ingredient matches for Bisacodyl Nizhpharm



Bisacodyl

Bisacodyl is reported as an ingredient of Bisacodyl Nizhpharm in the following countries:


  • Latvia

International Drug Name Search

Saturday, November 13, 2010

Novapirina




Novapirina may be available in the countries listed below.


Ingredient matches for Novapirina



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Novapirina in the following countries:


  • Italy

International Drug Name Search

Thursday, November 11, 2010

Nitrofurantoina Lch




Nitrofurantoina Lch may be available in the countries listed below.


Ingredient matches for Nitrofurantoina Lch



Nitrofurantoin

Nitrofurantoin is reported as an ingredient of Nitrofurantoina Lch in the following countries:


  • Peru

International Drug Name Search

Saturday, November 6, 2010

Ibuprofeno Ur




Ibuprofeno Ur may be available in the countries listed below.


Ingredient matches for Ibuprofeno Ur



Ibuprofen

Ibuprofen is reported as an ingredient of Ibuprofeno Ur in the following countries:


  • Spain

International Drug Name Search

Friday, November 5, 2010

Eucaliptine




Eucaliptine may be available in the countries listed below.


Ingredient matches for Eucaliptine



Guaiacol

Guaiacol is reported as an ingredient of Eucaliptine in the following countries:


  • Mexico

International Drug Name Search

Thursday, November 4, 2010

Etoposido Microsules




Etoposido Microsules may be available in the countries listed below.


Ingredient matches for Etoposido Microsules



Etoposide

Etoposide is reported as an ingredient of Etoposido Microsules in the following countries:


  • Argentina

International Drug Name Search

Sunday, October 24, 2010

Ironate




Ironate may be available in the countries listed below.


Ingredient matches for Ironate



Iron Dextran

Iron Dextran is reported as an ingredient of Ironate in the following countries:


  • Greece

International Drug Name Search

Friday, October 22, 2010

Spasmoliv




Spasmoliv may be available in the countries listed below.


Ingredient matches for Spasmoliv



Scopolamine

Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Spasmoliv in the following countries:


  • Singapore

International Drug Name Search

Reticor




Reticor may be available in the countries listed below.


Ingredient matches for Reticor



Tretinoin

Tretinoin is reported as an ingredient of Reticor in the following countries:


  • Indonesia

International Drug Name Search

Thursday, October 21, 2010

Bortezomib




In the US, Bortezomib (bortezomib systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Lymphoma and Multiple Myeloma.

US matches:

  • Bortezomib

  • Bortezomib Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01XX32

CAS registry number (Chemical Abstracts Service)

0179324-69-7

Chemical Formula

C19-H25-B-N4-O4

Molecular Weight

384

Therapeutic Category

Antineoplastic agent

Chemical Names

{(1R)-3-methyl-1-[(2S)-3-phenyl-2-(pyrazin-2-carboxamido)propanamido]butyl}boronic acid (WHO)

Boronic acid, [(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2[(pyrazinylcarbonyl)amino]propyl]amino]butyl]- (USAN)

N-[(1S)-1-benzyl-2-{[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-amino}-2-oxoethyl]- pyrazinecarboxamid (IUPAC)

Foreign Names

  • Bortezomibum (Latin)
  • Bortezomib (German)
  • Bortézomib (French)
  • Bortezomib (Spanish)

Generic Names

  • Bortezomib (OS: BAN, USAN)
  • LDP-341 (IS)
  • MG 341 (IS)
  • MLN-341 (IS)
  • NSC 681239 (IS)
  • PS-341 (IS)

Brand Names

  • Velcade
    Ben Venue, China; Ben Venue, Oman; Janssen, Antigua & Barbuda; Janssen, Netherlands Antilles; Janssen, Argentina; Janssen, Australia; Janssen, Aruba; Janssen, Barbados; Janssen, Belgium; Janssen, Bermuda; Janssen, Bahamas; Janssen, Colombia; Janssen, Czech Republic; Janssen, Germany; Janssen, Ecuador; Janssen, Spain; Janssen, Finland; Janssen, Grenada; Janssen, Guyana; Janssen, Hong Kong; Janssen, Hungary; Janssen, Israel; Janssen, Iceland; Janssen, Italy; Janssen, Jamaica; Janssen, Cayman Islands; Janssen, Saint Lucia; Janssen, Luxembourg; Janssen, Mexico; Janssen, Netherlands; Janssen, Norway; Janssen, New Zealand; Janssen, Philippines; Janssen, Poland; Janssen, Romania; Janssen, Serbia; Janssen, Russian Federation; Janssen, Slovenia; Janssen, Slovakia; Janssen, Suriname; Janssen, Thailand; Janssen, Trinidad & Tobago; Janssen, Taiwan; Janssen, Saint Vincent & The Grenadines; Janssen, Venezuela; Janssen Pharmaceutical K.K., Japan; Janssen-Cilag, Austria; Janssen-Cilag, Switzerland; Janssen-Cilag, Chile; Janssen-Cilag, Denmark; Janssen-Cilag, France; Janssen-Cilag, Indonesia; Janssen-Cilag, Turkey; Janssen-Cilag, Vietnam; Janssen-Cilag, South Africa; Janssen-Ortho Inc., Canada; Johnson & Johnson, Croatia (Hrvatska); Millennium, United States; Ortho Biotech, United Kingdom


  • VELCADE
    Janssen-Cilag, Sweden

International Drug Name Search

Glossary

BANBritish Approved Name
IUPACInternational Union of Pure and Applied Chemistry
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, October 20, 2010

Y-45




Y-45 may be available in the countries listed below.


Ingredient matches for Y-45



Testosterone

Testosterone is reported as an ingredient of Y-45 in the following countries:


  • Bangladesh

International Drug Name Search

Wednesday, October 13, 2010

Trimétazidine Zydus




Trimétazidine Zydus may be available in the countries listed below.


Ingredient matches for Trimétazidine Zydus



Trimetazidine

Trimetazidine dihydrochloride (a derivative of Trimetazidine) is reported as an ingredient of Trimétazidine Zydus in the following countries:


  • France

International Drug Name Search

Saturday, October 9, 2010

Besitran




Besitran may be available in the countries listed below.


Ingredient matches for Besitran



Sertraline

Sertraline hydrochloride (a derivative of Sertraline) is reported as an ingredient of Besitran in the following countries:


  • Spain

International Drug Name Search

Kids-B




Kids-B may be available in the countries listed below.


Ingredient matches for Kids-B



Zinc Sulfate

Zinc Sulfate is reported as an ingredient of Kids-B in the following countries:


  • Bangladesh

International Drug Name Search

Thursday, October 7, 2010

Quinapril Apotex Farma




Quinapril Apotex Farma may be available in the countries listed below.


Ingredient matches for Quinapril Apotex Farma



Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Quinapril Apotex Farma in the following countries:


  • Spain

International Drug Name Search

Wednesday, October 6, 2010

Betasone




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Betasone



Betamethasone

Betamethasone is reported as an ingredient of Betasone in the following countries:


  • Oman

Betamethasone 17α,21-dipropionate (a derivative of Betamethasone) is reported as an ingredient of Betasone in the following countries:


  • Ethiopia

Betamethasone 17α,21-dipropionate and 21-(disodium phosphate) (a derivative of Betamethasone) is reported as an ingredient of Betasone in the following countries:


  • United States

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Betasone in the following countries:


  • Argentina

  • Bahrain

  • Oman

  • Singapore

International Drug Name Search

Tuesday, October 5, 2010

PMS-Lorazepam




PMS-Lorazepam may be available in the countries listed below.


Ingredient matches for PMS-Lorazepam



Lorazepam

Lorazepam is reported as an ingredient of PMS-Lorazepam in the following countries:


  • Canada

International Drug Name Search

Friday, October 1, 2010

Gine Canesten




Gine Canesten may be available in the countries listed below.


Ingredient matches for Gine Canesten



Clotrimazole

Clotrimazole is reported as an ingredient of Gine Canesten in the following countries:


  • Spain

International Drug Name Search

Monday, September 27, 2010

Taracycline




Taracycline may be available in the countries listed below.


Ingredient matches for Taracycline



Tetracycline

Tetracycline is reported as an ingredient of Taracycline in the following countries:


  • Bangladesh

International Drug Name Search

Sunday, September 26, 2010

Glycon




Glycon may be available in the countries listed below.


Ingredient matches for Glycon



Gliclazide

Gliclazide is reported as an ingredient of Glycon in the following countries:


  • Thailand

International Drug Name Search

Sunday, September 19, 2010

Orajel Baby Nighttime


Generic Name: benzocaine topical (BENZ oh kane TOP ik al)

Brand Names: Americaine, Americaine Hemorrhoidal, Anacaine, Anbesol Gel, Anbesol Liquid, Babee Teething Lotion, Benzo-O-Stetic, Boil Ease Pain Relieving, Cepacol Extra Strength, Cepacol Fizzlers, Dent-O-Kain, Dermoplast, Detane, Hurricaine, Lanacane, Maintain, Medicone Maximum Strength, Num-Zit, Numzident, Orabase, Orabase Gel-B, Orajel, Orajel Denture, Oral Pain Relief, OraMagic Plus, Outgro Pain Relief, Retre-Gel, Rid-A-Pain, Skeeter Stik, Solarcaine Aerosol, Sting-Kill, Topex, Trocaine, Vagisil Feminine Cream, zilactin-B


What is Orajel Baby Nighttime (benzocaine topical)?

Benzocaine is a local anesthetic (numbing medication). It works by blocking nerve signals in your body.


Benzocaine topical is used to reduce pain or discomfort caused by minor skin irritations, sore throat, sunburn, teething pain, vaginal or rectal irritation, ingrown toenails, hemorrhoids, and many other sources of minor pain on a surface of the body. Benzocaine is also used to numb the skin or surfaces inside the mouth, nose, throat, vagina, or rectum to lessen the pain of inserting a medical instrument such as a tube or speculum.


There are many brands and forms of benzocaine topical available and not all brands are listed on this leaflet.


Benzocaine topical may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Orajel Baby Nighttime (benzocaine topical)?


There are many brands and forms of benzocaine topical available and not all brands are listed on this leaflet.


Benzocaine topical used in the mouth or throat may cause a life-threatening condition in which the amount of oxygen in your blood stream becomes dangerously low. This condition is called methemoglobinemia (met-HEEM-oh glo-bin-EE-mee-a) and it may occur after only one use of benzocaine or after several uses.

Signs and symptoms of methemoglobinemia may occur within minutes or up to 2 hours after using benzocaine topical in the mouth or throat. GET EMERGENCY MEDICAL HELP IF YOU HAVE ANY OF THESE SYMPTOMS: headache, tired feeling, confusion, fast heart rate, and feeling light-headed or short of breath, with a pale, blue, or gray appearance of your skin, lips, or fingernails.


Do not use benzocaine topical if you have ever had methemoglobinemia in the past. Do not use this medicine on a child younger than 2 years old without medical advice. An overdose of numbing medications can cause fatal side effects if too much of the medicine is absorbed through your skin and into your blood. This is more likely to occur when using a numbing medicine without the advice of a medical doctor (such as during a cosmetic procedure like laser hair removal). Overdose symptoms may include uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

Use the smallest amount of this medication needed to numb the skin or relieve pain. Do not use large amounts of benzocaine topical, or cover treated skin areas with a bandage or plastic wrap without medical advice. Be aware that many cosmetic procedures are performed without a medical doctor present.


Your body may absorb more of this medication if you use too much, if you apply it over large skin areas, or if you apply heat, bandages, or plastic wrap to treated skin areas. Skin that is cut or irritated may also absorb more topical medication than healthy skin.

Before using benzocaine topical, tell your doctor if you have any type of inherited enzyme deficiency, heart disease, a breathing disorder such as asthma, bronchitis, or emphysema, or if you smoke.


If you are treating a sore throat, call your doctor if the pain is severe or lasts longer than 2 days, especially if you also develop a fever, headache, skin rash, swelling, nausea, vomiting, cough, or breathing problems.


What should I discuss with my health care provider before using Orajel Baby Nighttime (benzocaine topical)?


Do not use benzocaine topical if you have ever had methemoglobinemia in the past. An overdose of numbing medications can cause fatal side effects if too much of the medicine is absorbed through your skin and into your blood. This is more likely to occur when using a numbing medicine without the advice of a medical doctor (such as during a cosmetic procedure like laser hair removal). Overdose symptoms may include uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:



  • asthma, bronchitis, emphysema, or other breathing disorder;




  • heart disease;




  • a personal or family history of methemoglobinemia, or any genetic (inherited) enzyme deficiency; or




  • if you smoke.




FDA pregnancy category C. It is not known whether benzocaine topical will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication.. It is not known whether benzocaine topical passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Do not use this medicine on a child younger than 2 years old without medical advice.

How should I use Orajel Baby Nighttime (benzocaine topical)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended.


Your body may absorb more of this medication if you use too much, if you apply it over large skin areas, or if you apply heat, bandages, or plastic wrap to treated skin areas. Skin that is cut or irritated may also absorb more topical medication than healthy skin.

Use the smallest amount of medicine needed to numb the skin or relieve pain. Do not use large amounts of benzocaine topical, or cover treated skin areas with a bandage or plastic wrap without medical advice. Be aware that many cosmetic procedures are performed without a medical doctor present.


This medication comes with instructions for safe and effective application. Follow these directions carefully. Ask your doctor or pharmacist if you have any questions.


To treat minor skin conditions, apply a thin layer of benzocaine topical to the affected area up to 4 times per day. If using the spray, hold the container 6 to 12 inches away from the skin. Do not spray this medication onto your face. Spray it instead on your hands and then rub it onto the face, avoiding contact with your eyes.


To treat hemorrhoids, clean the area with soap and water before applying benzocaine topical. Apply the medication up to 6 times per day. If you are using the rectal suppository, try to empty your bowel and bladder before inserting the suppository. Remove the outer wrapper from the suppository before inserting it. Avoid handling the suppository too long or it will melt in your hands.


Do not use benzocaine topical to treat large skin areas or deep puncture wounds. Avoid using the medicine on skin that is raw or blistered, such as a severe burn or abrasion.

Call your doctor if your symptoms do not improve or if they get worse within the first 7 days of using benzocaine topical. Also call your doctor if your symptoms had cleared up but then came back.


If you are treating a sore throat, call your doctor if the pain is severe or lasts longer than 2 days, especially if you also develop a fever, headache, skin rash, swelling, nausea, vomiting, cough, or breathing problems.


Store at room temperature away from moisture and heat. Do not freeze.

What happens if I miss a dose?


Since benzocaine topical is used as needed, you may not be on a dosing schedule. If you are using the medication regularly, use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222. An overdose of benzocaine topical applied to the skin can cause life-threatening side effects such as uneven heartbeats, seizure (convulsions), coma, slowed breathing, or respiratory failure (breathing stops).

What should I avoid while taking Orajel Baby Nighttime (benzocaine topical)?


Avoid eating within 1 hour after using benzocaine topical on your gums or inside your mouth.


Benzocaine topical is for use only on the surface of your body, or just inside the mouth, vagina, or rectum. Avoid getting this medication in your eyes. Avoid swallowing the gel, liquid, or ointment while applying it to your gums or the inside of your mouth. The throat spray or oral lozenge may be swallowed gradually during use.

Do not apply other medications to the same affected areas you treat with benzocaine topical, unless your doctor has told you otherwise.


Orajel Baby Nighttime (benzocaine topical) side effects


Benzocaine topical used in the mouth or throat may cause a life-threatening condition in which the amount of oxygen in your blood stream becomes dangerously low. This condition is called methemoglobinemia (met-HEEM-oh glo-bin-EE-mee-a) and it may occur after only one use of benzocaine or after several uses.

Signs and symptoms may occur within minutes or up to 2 hours after using benzocaine topical in the mouth or throat. GET EMERGENCY MEDICAL HELP IF YOU HAVE:



  • headache, tired feeling, confusion;




  • fast heart rate;




  • feeling light-headed or short of breath; and




  • pale, blue, or gray appearance of your skin, lips, or fingernails.




Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using benzocaine topical and call your doctor at once if you have any of these other serious side effects:

  • headache, weakness, dizziness, breathing problems, fast heart rate, and gray or bluish colored skin (rare but serious side effects of benzocaine);




  • severe burning, stinging, or sensitivity where the medicine is applied;




  • swelling, warmth, or redness; or




  • oozing, blistering, or any signs of infection.



Less serious side effects may include:



  • mild stinging, burning, or itching where the medicine is applied;




  • skin tenderness or redness; or




  • dry white flakes where the medicine was applied.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Orajel Baby Nighttime (benzocaine topical)?


It is not likely that other drugs you take orally or inject will have an effect on topically applied benzocaine topical. But many drugs can interact with each other. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Orajel Baby Nighttime resources


  • Orajel Baby Nighttime Side Effects (in more detail)
  • Orajel Baby Nighttime Use in Pregnancy & Breastfeeding
  • Orajel Baby Nighttime Support Group
  • 0 Reviews for Orajel Baby Nighttime - Add your own review/rating


  • Americaine Ointment MedFacts Consumer Leaflet (Wolters Kluwer)

  • Anacaine Advanced Consumer (Micromedex) - Includes Dosage Information

  • Anbesol Extra Strength Advanced Consumer (Micromedex) - Includes Dosage Information

  • Benz-O-Sthetic Gel MedFacts Consumer Leaflet (Wolters Kluwer)

  • Lanacane Aerosol Spray MedFacts Consumer Leaflet (Wolters Kluwer)

  • OraMagic Plus Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • Rid-A-Pain Topical Advanced Consumer (Micromedex) - Includes Dosage Information



Compare Orajel Baby Nighttime with other medications


  • Oral and Dental Conditions


Where can I get more information?


  • Your pharmacist can provide more information about benzocaine topical.

See also: Orajel Baby Nighttime side effects (in more detail)


Tuesday, September 14, 2010

Gemcitabin Actavis




Gemcitabin Actavis may be available in the countries listed below.


Ingredient matches for Gemcitabin Actavis



Gemcitabine

Gemcitabine hydrochloride (a derivative of Gemcitabine) is reported as an ingredient of Gemcitabin Actavis in the following countries:


  • Austria

  • Germany

  • Ireland

  • Sweden

  • Switzerland

International Drug Name Search

Sunday, September 12, 2010

Betimol Drops


Pronunciation: TIM-oh-lol
Generic Name: Timolol
Brand Name: Betimol


Betimol Drops are used for:

Treating increased pressure in the eye (ocular hypertension) and open-angle glaucoma. It may also be used for other conditions as determined by your doctor.


Betimol Drops are a beta-blocker. It works to decrease fluid production and pressure inside the eye.


Do NOT use Betimol Drops if:


  • you are allergic to any ingredient in Betimol Drops

  • you have severe chronic obstructive pulmonary disease (COPD) or a history of asthma

  • you have heart block, heart failure, or an unusually slow heartbeat

  • you are in shock caused by severe heart problems

  • you are using another beta-blocker eye drop (eg, betaxolol)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Betimol Drops:


Some medical conditions may interact with Betimol Drops. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of lung or breathing problems (eg, bronchitis, COPD, emphysema), diabetes, low blood sugar, heart problems, certain muscle problems (eg, myasthenia gravis, muscle weakness), blood vessel problems, or an overactive thyroid

  • if you have narrow-angle glaucoma, double vision, a drooping eyelid, or an eye infection or injury

Some MEDICINES MAY INTERACT with Betimol Drops. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Bupivacaine, calcium channel blockers (eg, verapamil), certain antiarrhythmics (eg, disopyramide, flecainide, quinidine), cimetidine, digoxin, ketanserin, reserpine, or selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine) because serious heart problems (eg, conduction problems, heart failure, slow heartbeat) or low blood pressure may occur

  • Clonidine because increased blood pressure may occur

  • Insulin or oral antidiabetics (eg, glyburide, repaglinide) because the risk of low blood sugar (eg, dizziness, headache, hunger, shakiness or weakness, sweating) or slow heart rate may be increased. Betimol Drops may also hide certain signs of low blood sugar

  • Alpha-blockers (eg, alfuzosin, prazosin), oral beta-blockers (eg, propranolol), or other beta-blocker eye drops (eg, betaxolol) because the risk of their side effects may be increased by Betimol Drops

  • Certain sympathomimetics (eg, albuterol, salmeterol), epinephrine, or theophylline because their effectiveness may be decreased by Betimol Drops

This may not be a complete list of all interactions that may occur. Ask your health care provider if Betimol Drops may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Betimol Drops:


Use Betimol Drops as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Betimol Drops are only for the eye. Do not get it in your nose or mouth.

  • Soft contact lenses may absorb a chemical in Betimol Drops. Remove contact lenses before you use Betimol Drops; lenses may be placed back in the eyes 5 minutes after use of Betimol Drops.

  • To use Betimol Drops in the eye, first, wash your hands. Tilt your head back. Using your index finger, pull the lower eyelid away from the eye to form a pouch. Drop the medicine into the pouch and gently close your eyes. Immediately use your finger to apply pressure to the inside corner of the eye for 1 to 2 minutes. Do not blink. Remove excess medicine around your eye with a clean, dry tissue, being careful not to touch your eye. Wash your hands to remove any medicine that may be on them.

  • To prevent germs from contaminating your medicine, do not touch the applicator tip to any surface, including the eye. Keep the container tightly closed.

  • Use Betimol Drops at least 5 minutes before or after any other medicine that you put in your eye.

  • Using Betimol Drops at the same time each day will help you remember to use it.

  • Continue to use Betimol Drops even if you feel well. Do not miss any doses.

  • If you miss a dose of Betimol Drops, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Betimol Drops.



Important safety information:


  • Betimol Drops may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Betimol Drops with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Tell your doctor or dentist that you take Betimol Drops before you receive any medical or dental care, emergency care, or surgery.

  • Contact your doctor if you have an eye injury or infection, or if you will be having eye surgery.

  • Diabetes patients - Betimol Drops may hide signs of low blood sugar, such as a rapid heartbeat. Be sure to watch for other signs of low blood sugar. Low blood sugar may make you anxious, sweaty, weak, dizzy, drowsy, or faint. It may also make your vision change; give you a headache, chills, or tremors; or make you more hungry. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.

  • If you have a history of any severe allergic reaction, talk with your doctor. You may be at risk for an even more severe allergic reaction if you come into contact with the substance that caused your allergy. Some medicines used to treat severe allergies may also not work as well while you are using Betimol Drops.

  • Betimol Drops may cause harm if it is swallowed. If you may have taken it by mouth, contact your poison control center or emergency room right away.

  • Lab tests, including eye pressure, may be performed while you use Betimol Drops. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Betimol Drops should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Betimol Drops while you are pregnant. Betimol Drops are found in breast milk. Do not breast-feed while taking Betimol Drops.


Possible side effects of Betimol Drops:


All medicines may cause side effects, but many people have no, or minor side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Blurred vision; dizziness; dry eyes; feeling that something is in your eye; headache; increased tear production; minor burning, itching, or stinging of the eye; nausea.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest pain or discomfort; confusion; eye irritation, swelling, pain, or discharge; eyelid pain, redness, scaling, drooping, or swelling; fainting; pain, numbness, weakness, or tingling of an arm or leg; severe or persistent headache or dizziness; shortness of breath; slow or irregular heartbeat; sudden unusual weight gain; swelling of the hands, ankles, or feet; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Betimol side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include chest pain; difficulty breathing or shortness of breath; severe or persistent dizziness or headache; slow or irregular heartbeat.


Proper storage of Betimol Drops:

Store Betimol Drops at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Protect from freezing. Store away from heat, moisture, and light. Keep Betimol Drops out of the reach of children and away from pets.


General information:


  • If you have any questions about Betimol Drops, please talk with your doctor, pharmacist, or other health care provider.

  • Betimol Drops are to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Betimol Drops. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Betimol resources


  • Betimol Side Effects (in more detail)
  • Betimol Use in Pregnancy & Breastfeeding
  • Betimol Drug Interactions
  • Betimol Support Group
  • 0 Reviews for Betimol - Add your own review/rating


Compare Betimol with other medications


  • Glaucoma, Open Angle
  • Intraocular Hypertension

Saturday, September 11, 2010

Nisoldipine




In the US, Nisoldipine (nisoldipine systemic) is a member of the drug class calcium channel blocking agents and is used to treat Angina Pectoris Prophylaxis, High Blood Pressure and Raynaud's Syndrome.

US matches:

  • Nisoldipine Extended-Release Tablets

  • Nisoldipine

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C08CA07

CAS registry number (Chemical Abstracts Service)

0063675-72-9

Chemical Formula

C20-H24-N2-O6

Molecular Weight

388

Therapeutic Category

Calcium channel blocker

Chemical Name

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester, (±)-

Foreign Names

  • Nisoldipinum (Latin)
  • Nisoldipin (German)
  • Nisoldipine (French)
  • Nisoldipino (Spanish)

Generic Names

  • Nisoldipina (OS: DCIT)
  • Nisoldipine (OS: USAN, DCF, JAN, BAN)
  • Bay K 5552 (IS: Bayer)

Brand Names

  • Baymycard
    Bayer, Germany; Bayer, Hungary; Bayer, Romania; Bayer Yakuhin, Japan


  • Corasol
    Sanitas, Chile


  • Nikameal
    Towa Yakuhin, Japan


  • Ninobarucin
    Choseido Pharmaceutical, Japan


  • Nisoldipine
    Mylan, United States


  • Nisomynard
    Yoshindo, Japan


  • Nivas
    Tecnofarma, Chile


  • Nizoldin
    Slaviamed, Serbia


  • Riohard
    Taiyo Pharmaceutical, Japan


  • Sular
    Bayer, Belgium; Bayer Animal Health, Luxembourg; Bayer Schering Pharma, Spain; Shionogi, United States


  • Syscor
    AstraZeneca, Guyana; Bayer, Austria; Bayer, Belgium; Bayer, Finland; Bayer, Greece; Bayer, Italy; Bayer, Taiwan; Bayer Animal Health, Luxembourg; Bayer Schering Pharma, Spain; Eurim, Austria; Forest, United Kingdom

International Drug Name Search

Glossary

BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, September 9, 2010

Amchafibrin




Amchafibrin may be available in the countries listed below.


Ingredient matches for Amchafibrin



Tranexamic Acid

Tranexamic Acid is reported as an ingredient of Amchafibrin in the following countries:


  • Spain

International Drug Name Search

Tuesday, September 7, 2010

Paracetamol Walker




Paracetamol Walker may be available in the countries listed below.


Ingredient matches for Paracetamol Walker



Paracetamol

Paracetamol is reported as an ingredient of Paracetamol Walker in the following countries:


  • Argentina

International Drug Name Search

Wednesday, September 1, 2010

Exel




Exel may be available in the countries listed below.


Ingredient matches for Exel



Meloxicam

Meloxicam is reported as an ingredient of Exel in the following countries:


  • Mexico

International Drug Name Search

Thursday, August 26, 2010

Laktulose PS




Laktulose PS may be available in the countries listed below.


Ingredient matches for Laktulose PS



Lactulose

Lactulose is reported as an ingredient of Laktulose PS in the following countries:


  • Denmark

International Drug Name Search

Monday, August 23, 2010

Carbon Oriental




Carbon Oriental may be available in the countries listed below.


Ingredient matches for Carbon Oriental



Charcoal

Charcoal, Activated is reported as an ingredient of Carbon Oriental in the following countries:


  • Argentina

International Drug Name Search

Saturday, August 21, 2010

brompheniramine, dihydrocodeine, and phenylephrine


Generic Name: brompheniramine, dihydrocodeine, and phenylephrine (BROM fen IR a meen, dye HYE dro KOE deen, FEN il EFF rin)

Brand names: Poly-Tussin DHC, EndaCof-DH


What is brompheniramine, dihydrocodeine, and phenylephrine?

Brompheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Dihydrocodeine is a narcotic cough suppressant.


Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


The combination of brompheniramine, dihydrocodeine, and phenylephrine is used to treat nasal congestion, sneezing, runny nose, and cough caused by the common cold.


Dihydrocodeine will not treat a cough that is caused by smoking, asthma, or emphysema.


Brompheniramine, dihydrocodeine, and phenylephrine may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about brompheniramine, dihydrocodeine, and phenylephrine?


Do not use this medication if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take a cough and cold medicine before the MAO inhibitor has cleared from your body. You should not use brompheniramine, dihydrocodeine, and phenylephrine if you are allergic to it, or if you have peptic ulcer, severe or uncontrolled high blood pressure, severe coronary artery disease, ischemic heart disease (reduced circulation of blood to the heart), narrow-angle glaucoma, if you are breast-feeding a baby, or if you are unable to urinate.

Before taking this medication, tell your doctor if you have heart disease or high blood pressure, asthma or other breathing disorder, diabetes, a thyroid disorder, glaucoma, kidney or liver disease, gallbladder disease, pancreatitis, Addison's disease or other adrenal gland disorder, a seizure disorder, head injury or brain tumor, an enlarged prostate, problems with urination, mental illness, or a history of drug or alcohol addiction.


Always ask a doctor before giving cough or cold medicine to a child. Death can occur from the misuse of cough or cold medicine in very young children. Brompheniramine, dihydrocodeine, and phenylephrine should not be given to a child younger than 6 years old.

What should I discuss with my healthcare provider before taking brompheniramine, dihydrocodeine, and phenylephrine?


Do not use this medication if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take a cough and cold medicine before the MAO inhibitor has cleared from your body. You should also not take codeine if you are having an asthma attack or if you have a bowel obstruction called paralytic ileus. You should not use brompheniramine, dihydrocodeine, or phenylephrine, if you have ever had an allergic reaction to it, or if you have:

  • severe or uncontrolled high blood pressure;




  • severe coronary artery disease;




  • narrow-angle glaucoma;




  • peptic ulcer;




  • if you are unable to urinate;




  • if you are pregnant;




  • if you are having an asthma attack.



If you have certain conditions, you may need a dose adjustment or special tests to safely take brompheniramine, dihydrocodeine, and phenylephrine. Before taking this medication, tell your doctor if you have:



  • heart disease or high blood pressure;




  • ischemic heart disease (reduced circulation of blood to the heart);




  • asthma, COPD, or other breathing disorder;




  • glaucoma;




  • diabetes;



  • kidney or liver disease;


  • a thyroid disorder;




  • enlarged prostate, urination problems;




  • gallbladder disease or pancreatitis;




  • Addison's disease or other adrenal gland disorders;




  • a history of head injury or brain tumor;




  • epilepsy or other seizure disorder;




  • mental illness; or




  • a history of drug or alcohol addiction.




FDA pregnancy category C. This medication may be harmful to an unborn baby. Dihydrocodeine may cause breathing problems or addiction/withdrawal symptoms in a newborn. Tell your doctor if you are pregnant or plan to become pregnant while you are taking this medication. This medication can pass into breast milk and may harm a nursing baby. The use of dihydrocodeine by some nursing mothers may lead to life-threatening side effects in the baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Older adults may be more sensitive to the side effects of this medication. Dihydrocodeine may be habit-forming and should be used only by the person it was prescribed for. This medication should never be shared with another person, especially someone who has a history of drug abuse or addiction. Keep the medication in a secure place where others cannot get to it.

How should I take brompheniramine, dihydrocodeine, and phenylephrine?


Take this medication exactly as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor. Follow the directions on your prescription label. Cold medicine is usually taken for only a short time until your symptoms clear up.


Always ask a doctor before giving cough or cold medicine to a child. Death can occur from the misuse of cough or cold medicine in very young children. Brompheniramine, dihydrocodeine, and phenylephrine should not be given to a child younger than 6 years old. Take the medicine with a full glass of water.

Measure liquid medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache or skin rash. Store brompheniramine, dihydrocodeine, and phenylephrine at room temperature away from moisture and heat.

Keep track of how much of this medicine has been used from the bottle. Dihydrocodeine is a drug of abuse and you should be aware if any person in the household is using this medicine improperly or without a prescription.


See also: Brompheniramine, dihydrocodeine, and phenylephrine dosage (in more detail)

What happens if I miss a dose?


Since cough and cold medicine is usually taken only as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine. An overdose of dihydrocodeine can be fatal.

Overdose symptoms may include extreme drowsiness, pinpoint pupils, cold and clammy skin, limp muscles, fainting, seizure (convulsions), shallow breathing or breathing that stops.


What should I avoid while taking brompheniramine, dihydrocodeine, and phenylephrine?


This medication can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol while you are taking this medication. Alcohol can add to the side effects of brompheniramine, dihydrocodeine, and phenylephrine.

Tell your doctor if you regularly use other medicines that make you sleepy (such as pain medication, sleeping pills, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by brompheniramine, dihydrocodeine, and phenylephrine.


Do not use any other over-the-counter cold, allergy, or pain medication without first asking your doctor or pharmacist. Brompheniramine or phenylephrine are contained in many medicines available over the counter. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains brompheniramine or phenylephrine.

Brompheniramine, dihydrocodeine, and phenylephrine side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these serious side effects:

  • fast or pounding heartbeat;




  • feeling like you might pass out;




  • weak or shallow breathing;




  • confusion, hallucinations;




  • severe dizziness, anxiety, restless feeling, or nervousness;




  • seizure (convulsions); or




  • painful or difficult urination.



Less serious side effects may include:



  • dizziness, drowsiness, headache, tired feeling;




  • feeling excited or restless;




  • increased dreaming;




  • increased sweating or urination;




  • nausea, vomiting, diarrhea, constipation, loss of appetite;




  • dry mouth;




  • blurred vision, dry eyes; or




  • mild skin rash or itching.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


Brompheniramine, dihydrocodeine, and phenylephrine Dosing Information


Usual Adult Dose for Cough and Nasal Congestion:

Brompheniramine/dihydrocodeine/phenylephrine 4 mg-3 mg-7.5 mg/5 mL oral liquid:
5 mL orally every 4 to 6 hours not to exceed 30 mL daily.

Usual Pediatric Dose for Cough and Nasal Congestion:

Brompheniramine/dihydrocodeine/phenylephrine 4 mg-3 mg-7.5 mg/5 mL oral liquid:
6 to 11 years: 2.5 mL orally every 4 to 6 hours not to exceed 15 mL daily.
12 years or older: 5 mL orally every 4 to 6 hours not to exceed 30 mL daily.


What other drugs will affect brompheniramine, dihydrocodeine, and phenylephrine?


Tell your doctor about all other medicines you use, especially:



  • methyldopa (Aldomet);




  • mecamylamine (Inversine);




  • reserpine;




  • promethazine (Phenergan, Adgan, Anergan 50, Pentazine);




  • a beta-blocker such as atenolol (Tenormin), carteolol (Cartrol), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal), sotalol (Betapace), timolol (Blocadren), and others; or




  • an antidepressant such as amitriptyline (Elavil), clomipramine (Anafranil), imipramine (Janimine, Tofranil), and others.



This list is not complete and there may be other drugs that can interact with brompheniramine, dihydrocodeine, and phenylephrine. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More brompheniramine, dihydrocodeine, and phenylephrine resources


  • Brompheniramine, dihydrocodeine, and phenylephrine Dosage
  • Brompheniramine, dihydrocodeine, and phenylephrine Use in Pregnancy & Breastfeeding
  • Brompheniramine, dihydrocodeine, and phenylephrine Drug Interactions
  • Brompheniramine, dihydrocodeine, and phenylephrine Support Group
  • 0 Reviews for Brompheniramine, dihydrocodeine, and phenylephrine - Add your own review/rating


Compare brompheniramine, dihydrocodeine, and phenylephrine with other medications


  • Cold Symptoms
  • Cough and Nasal Congestion


Where can I get more information?


  • Your pharmacist can provide more information about brompheniramine, dihydrocodeine, and phenylephrine.


Thursday, August 19, 2010

Dilaclan




Dilaclan may be available in the countries listed below.


Ingredient matches for Dilaclan



Diltiazem

Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Dilaclan in the following countries:


  • Spain

International Drug Name Search

Sunday, August 8, 2010

Emetiral




Emetiral may be available in the countries listed below.


Ingredient matches for Emetiral



Prochlorperazine

Prochlorperazine maleate (a derivative of Prochlorperazine) is reported as an ingredient of Emetiral in the following countries:


  • Romania

International Drug Name Search

Friday, August 6, 2010

Cistidil




Cistidil may be available in the countries listed below.


Ingredient matches for Cistidil



Cystine

Cystine is reported as an ingredient of Cistidil in the following countries:


  • Italy

International Drug Name Search

Rutin




In the US, Rutin (bioflavonoids systemic) is a member of the drug class vitamins and is used to treat Osteoarthritis.

US matches:

  • Rutin

Ingredient matches for Rutin



Rutoside

Rutin (JAN) is also known as Rutoside (Rec.INN)

International Drug Name Search

Glossary

JANJapanese Accepted Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Thursday, August 5, 2010

Bicalutamida Sandoz




Bicalutamida Sandoz may be available in the countries listed below.


Ingredient matches for Bicalutamida Sandoz



Bicalutamide

Bicalutamide is reported as an ingredient of Bicalutamida Sandoz in the following countries:


  • Spain

International Drug Name Search

Tuesday, August 3, 2010

Orfenadrina




Orfenadrina may be available in the countries listed below.


Ingredient matches for Orfenadrina



Orphenadrine

Orfenadrina (DCIT) is known as Orphenadrine in the US.

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana

Click for further information on drug naming conventions and International Nonproprietary Names.

Sunday, August 1, 2010

Xifaxan




In the US, Xifaxan (rifaximin systemic) is a member of the drug class miscellaneous antibiotics and is used to treat Crohn's Disease, Diarrhea, Hepatic Encephalopathy, Irritable Bowel Syndrome and Traveler's Diarrhea.

US matches:

  • Xifaxan

Ingredient matches for Xifaxan



Rifaximin

Rifaximin is reported as an ingredient of Xifaxan in the following countries:


  • Germany

  • Poland

  • United States

International Drug Name Search

Tuesday, July 27, 2010

Cholelithiasis w/ Acute Cholecystitis and Obstruction Medications


There are currently no drugs listed for "Cholelithiasis w/ Acute Cholecystitis and Obstruction".

Learn more about Cholelithiasis w/ Acute Cholecystitis and Obstruction





Drug List:

Sunday, July 25, 2010

Netromicina




Netromicina may be available in the countries listed below.


Ingredient matches for Netromicina



Netilmicin

Netilmicin sulfate (a derivative of Netilmicin) is reported as an ingredient of Netromicina in the following countries:


  • Ecuador

  • Mexico

  • Portugal

  • Venezuela

International Drug Name Search

Friday, July 23, 2010

Nozepam




Nozepam may be available in the countries listed below.


Ingredient matches for Nozepam



Oxazepam

Oxazepam is reported as an ingredient of Nozepam in the following countries:


  • Latvia

  • Lithuania

International Drug Name Search

Thursday, July 22, 2010

Balminil Expectorant




In the US, Balminil Expectorant is a member of the drug class expectorants and is used to treat Bronchitis and Cough.

Ingredient matches for Balminil Expectorant



Guaifenesin

Guaifenesin is reported as an ingredient of Balminil Expectorant in the following countries:


  • Canada

International Drug Name Search

Monday, July 19, 2010

Freegen




Freegen may be available in the countries listed below.


Ingredient matches for Freegen



Carmellose

Carmellose is reported as an ingredient of Freegen in the following countries:


  • Peru

Carmellose sodium salt (a derivative of Carmellose) is reported as an ingredient of Freegen in the following countries:


  • Colombia

International Drug Name Search

Dy-G


Generic Name: dyphylline and guaifenesin (DYE fil in and gwye FEN e sin)

Brand Names: COPD, Difil G, Difil-G Forte, Dilex-G, Dilex-G 200, Dy-G, Dyflex-G, Dyphyllin-GG, Dyphylline GG, Dyphylline GG ES, Jay-Phyl, Lufyllin-GG, Panfil G


What is Dy-G (dyphylline and guaifenesin)?

Dyphylline is a bronchodilator. It works by relaxing muscles in the airways to improve breathing.


Guaifenesin is an expectorant. It helps loosen congestion in your chest and throat, making it easier to cough out through your mouth.


The combination of dyphylline and guaifenesin is used to treat cough and breathing problems caused by bronchial asthma, chronic bronchitis, or emphysema. This medication is not a cure for asthma, bronchitis, or emphysema.


Dyphylline and guaifenesin may also be used for purposes not listed in this medication guide.


What is the most important information I should know about dyphylline and Dy-G (dyphylline and guaifenesin)?


You should not use this medicine if you are allergic to dyphylline or guaifenesin. This medication will not treat an asthma attack.

Before taking this medication, tell your doctor if you have heart disease or a history of heart attack, high blood pressure, overactive thyroid, or a stomach ulcer.


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Drink extra fluids to help loosen the congestion and lubricate your throat while you are taking this medication. Ask a doctor or pharmacist before using any other cough or cold medicine. Guaifenesin is contained in many combination medicines. Taking certain products together can cause you to get too much guaifenesin. Check the label to see if a medicine contains guaifenesin.

What should I discuss with my healthcare provider before taking Dy-G (dyphylline and guaifenesin)?


You should not use this medicine if you are allergic to dyphylline or guaifenesin. This medication will not treat an asthma attack.

To make sure you can safely take this medication, tell your doctor if you have any of these other conditions:



  • heart disease or a history of heart attack;




  • high blood pressure;




  • overactive thyroid; or




  • a stomach ulcer.




FDA pregnancy category C. It is not known whether dyphylline and guaifenesin will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medication. Dyphylline and guaifenesin can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

How should I take Dy-G (dyphylline and guaifenesin)?


Take exactly as prescribed by your doctor. Do not take in larger or smaller amounts or for longer than recommended. Follow the directions on your prescription label.


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Drink extra fluids to help loosen the congestion and lubricate your throat while you are taking this medication. Take dyphylline and guaifenesin with food if it upsets your stomach.

Measure liquid medicine with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


This medication can cause unusual results with certain medical tests. Tell any doctor who treats you that you are using dyphylline and guaifenesin.


Store at room temperature away from moisture, heat, and light.

What happens if I miss a dose?


Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include nausea, vomiting, diarrhea, thirst, sweating, fast or slow heart rate, ringing in your ears, feeling anxious or irritable, and seizure (convulsions).


What should I avoid while taking Dy-G (dyphylline and guaifenesin)?


Ask a doctor or pharmacist before using any other cough or cold medicine. Guaifenesin is contained in many combination medicines. Taking certain products together can cause you to get too much guaifenesin. Check the label to see if a medicine contains guaifenesin.

Dy-G (dyphylline and guaifenesin) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Call your doctor at once if you have a serious side effect such as:

  • fast, pounding, or uneven heartbeats;




  • rapid breathing;




  • muscle twitching;




  • feeling like you might pass out;




  • seizure (convulsions); or




  • extreme thirst with headache, nausea, vomiting, and weakness.



Less serious side effects may include:



  • headache;




  • mild nausea, vomiting, or stomach pain;




  • feeling restless, agitated, or irritable;




  • sleep problems (insomnia); or




  • warmth, redness, or tingly feeling under your skin.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect dyphylline and guaifenesin ?


Tell your doctor about all other medicines you use, especially:



  • probenecid (Benemid);




  • aminophylline (Phyllocontin, Truphylline); or




  • theophylline (Elixophyllin, Theo-24, Uniphyl).



This list is not complete and other drugs may interact with dyphylline and guaifenesin. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Dy-G resources


  • Dy-G Side Effects (in more detail)
  • Dy-G Use in Pregnancy & Breastfeeding
  • Dy-G Drug Interactions
  • Dy-G Support Group
  • 0 Reviews for Dy-G - Add your own review/rating


  • COPD MedFacts Consumer Leaflet (Wolters Kluwer)

  • Dilex-G Liquid MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Dy-G with other medications


  • Asthma
  • Bronchitis


Where can I get more information?


  • Your pharmacist can provide more information about dyphylline and guaifenesin.

See also: Dy-G side effects (in more detail)


Sunday, July 18, 2010

diphtheria and tetanus vaccines


Generic Name: diphtheria and tetanus vaccines (DT, pediatric) (DIF thee ree ah and TET ah nus)

Brand names: Diphtheria-Tetanus Toxoids, Pediatric, Diphtheria-Tetanus Toxoids, Pediatric (obsolete)


What are diphtheria and tetanus vaccines?

Diphtheria and tetanus are serious diseases caused by bacteria. Diphtheria is spread from person to person. Tetanus enters the body through cuts or wounds. Vaccines for these diseases expose the individual to a small amount of the bacteria (or to a protein from the bacteria) and cause the body to develop immunity to the disease.


Diphtheria causes a thick coating in the nose, throat, and airway. It can lead to breathing problems, paralysis, heart failure, and even death.


Tetanus (Lockjaw) causes painful tightening of the muscles, usually all over the body. It can lead to "locking" of the jaw so the victim cannot open his mouth or swallow. Tetanus leads to death in about 1 out of 10 cases.


Diphtheria and tetanus vaccine (DT) can help prevent these diseases. DT is made for children younger than 7 years of age who cannot receive diphtheria, tetanus, and pertussis (DTP or DTaP) vaccine. Children younger than 7 years of age who have not gotten at least 3 doses of any tetanus and diphtheria vaccine (DTP, DTaP, DT, others) during their lifetime should do so using DT. After a child gets the third dose, a Td (a form diphtheria and tetanus vaccine for people 7 years of age and older) booster dose is needed every 10 years all through life. Many more people would get these diseases if vaccination did not occur.


What is the most important information I should know about diphtheria and tetanus vaccines?


Children with minor illnesses, such as a cold, may be vaccinated. Those who are moderately or severely ill should usually wait until they recover before getting DT vaccine.


What should I discuss with my healthcare provider before receiving diphtheria and tetanus vaccines?


A child who had a life-threatening allergic reaction after a dose of DT should not get another dose.

Before receiving DT vaccine, talk to your doctor if your child:



  • has HIV or AIDS or another disease that affects the immune system;




  • is taking a medication that affects the immune system (e.g. steroids, anti-rejection medications);




  • has cancer; or




  • is receiving cancer treatment with x-rays, radiation, or medication.



Ask your healthcare provider for more information. DT vaccine may not be recommended in some cases.


Children with minor illnesses, such as a cold, may be vaccinated. Those who are moderately or severely ill should usually wait until they recover before getting DT vaccine.


Talk to your doctor before receiving DT if you are pregnant or breast-feeding a baby.

How are diphtheria and tetanus vaccines administered?


Your doctor, nurse, or other healthcare provider will administer the diphtheria and tetanus vaccines as an injection.


DT is made for children younger than 7 years of age. Children who have not gotten at least 3 doses of any tetanus and diphtheria vaccine (DTP, DTaP, DT, others) during their lifetime should do so using DT. After a child gets the third dose, a Td (a form diphtheria and tetanus vaccine for people 7 years of age and older) booster dose is needed every 10 years all through life.


DT may be given at the same time as other vaccines.


Your doctor may recommend reducing pain or soreness from the injection by taking an aspirin-free pain reliever such as acetaminophen (Tylenol, Tempra, others) or ibuprofen (Motrin, Advil, others) when the shot is given and for the next 24-48 hours. Your healthcare provider can tell you the appropriate dosages of these medications.


What happens if I miss a dose?


Contact your doctor if a dose of DT vaccine is missed.


What happens if I overdose?


An overdose of DT vaccine is unlikely to occur.


What should I avoid before or after getting diphtheria and tetanus vaccines?


There are no restrictions on food, beverages, or activity before or after receiving the DT vaccine.


Diphtheria and tetanus vaccines side effects


Getting diphtheria or tetanus disease is much riskier than getting the DT vaccines. However, a vaccine, like any medicine, is capable of causing serious problems, such as severe allergic reactions. The risk of DT vaccine causing serious harm, or death, is extremely small.


Seek emergency medical attention or contact your doctor immediately if any of the following rare but serious side effects from DT vaccine are experienced:

  • a serious allergic reaction including swelling of the lips, tongue, or face; difficulty breathing; closing of the throat; hives; paleness; weakness; dizziness; or a fast heart beat; or




  • deep, aching pain and muscle wasting in the upper arm(s) starting 2 days to 4 weeks after the shot, and lasting up to many months.



Other less serious side effects, such as soreness redness, or swelling where the shot was given, may be more likely to occur. These side effects usually start within hours to a day or two after vaccination. They may last 1-2 days. Your doctor may recommend reducing pain or soreness from the injection by taking an aspirin-free pain reliever such as acetaminophen (Tylenol, Tempra, others) or ibuprofen (Motrin, Advil, others) when the shot is given and for the next 24-48 hours. Your healthcare provider can tell you the appropriate dosages of these medications.


Side effects other than those listed here may also occur. Contact your doctor about any side effect that seems unusual or that is especially bothersome.


Diphtheria and tetanus vaccines Dosing Information


Usual Adult Dose for Diphtheria Prophylaxis:

2 doses of 0.5 mL IM 4 to 6 weeks apart followed by a third dose of 0.5 mL after 6 to 12 months later.

A booster dose is recommended every 10 years.

Usual Adult Dose for Tetanus Prophylaxis:

2 doses of 0.5 mL IM 4 to 6 weeks apart followed by a third dose of 0.5 mL after 6 to 12 months later.

A booster dose is recommended every 10 years.

Usual Pediatric Dose for Diphtheria Prophylaxis:

>= 6 weeks to 1 year: Three doses of 0.5 mL IM at least 4 weeks apart followed by a fourth dose 6 to 12 months after the third dose.

>= 1 to 6 years: Two 0.5 mL IM doses given at least 4 weeks apart followed by a fourth dose 6 to 12 months after the third dose. If the final dose is given after the seventh birthday, use the adult dose.

>= 7 years: 2 doses of 0.5 mL IM 4 to 6 week apart followed by a third dose of 0.5 mL after 6 to 12 months later.


A booster dose is recommended every 10 years.

Usual Pediatric Dose for Tetanus Prophylaxis:

>= 6 weeks to 1 year: Three doses of 0.5 mL IM at least 4 weeks apart followed by a fourth dose 6 to 12 months after the third dose.

>= 1 to 6 years: Two 0.5 mL IM doses given at least 4 weeks apart followed by a fourth dose 6 to 12 months after the third dose. If the final dose is given after the seventh birthday, use the adult dose.

>= 7 years: 2 doses of 0.5 mL IM 4 to 6 week apart followed by a third dose of 0.5 mL after 6 to 12 months later.


A booster dose is recommended every 10 years.


What other drugs will affect diphtheria and tetanus vaccines?


Talk to your doctor before receiving DT vaccine if your child is taking any of the following medications that may affect the immune system:

  • an oral or injectable steroid medication such as betamethasone (Celestone), cortisone (Cortone), dexamethasone (Decadron, Dexone), hydrocortisone (Cortef, Hydrocortone), methylprednisolone (Medrol), prednisolone (Prelone, Pediapred), prednisone (Orasone, Deltasone, others), or triamcinolone (Aristocort);




  • an inhaled or nasal steroid such as beclomethasone (Qvar, Beclovent, Beconase, Vanceril, Vancenase), budesonide (Pulmicort, Rhinocort), flunisolide (Aerobid, Nasalide, Nasarel), fluticasone (Flovent, Flonase), mometasone (Nasonex), or triamcinolone (Azmacort, Nasacort);




  • treatment for cancer with chemotherapy (medication), radiation, or x-rays;




  • azathioprine (Imuran);




  • basiliximab (Simulect);




  • cyclosporine (Sandimmune, Neoral, Gengraf);




  • etanercept (Enbrel);




  • leflunomide (Arava);




  • muromonab-CD3 (Orthoclone);




  • mycophenolate mofetil (CellCept);




  • sirolimus (Rapamune); or




  • tacrolimus (Prograf).



It may not be recommended to receive DT vaccine if your child is taking any of the medications listed above.


Diphtheria and tetanus vaccines can be given at the same time as other vaccinations.



Where can I get more information?


  • Your doctor or pharmacist may have additional information or suggest additional resources regarding DT vaccines.